Scott Lim headshot
DL

David Scott Lim

Professor
Unit: School of Medicine
Department: Department of Medicine, Cardiovascular Medicine
Office location and address
1215 Lee St
Charlottesville, Virginia 22903
Education
Residency, Pediatrics, Wright State University, Dayton, Ohio
Clinical Fellowship, Pediatric Cardiology, The University of Michigan, Ann Arbor, MI
MD, Medicine, Mayo Medical School
Biography

Dr. Lim is medical director of the UVA Advanced Cardiac Valve Center and is noted internationally for his expertise in novel percutaneous approaches to heart valve disease. He specializes in children and adults with congenital heart disease. Dr. Lim is also the co-director of the Adult Congenital Heart Disease Center at UVA. He created and continues to run the humanitarian charity endeavor between UVA and Cedimat hospital in Santo Domingo, Dominican Republic, for care and education on rheumatic heart disease.

Clinical TRIal to EvaLUate Cardiovascular OutcoMes IN PAtients Treated with the Tricuspid ValvE Repair System Pivotal (TRILUMINATE Pivotal)
Source: Abbott Cardiovascular Systems, Inc
July 31, 2019 – July 31, 2025
MD-INMD-CV-Congenital Multicenter Trial of Pulmonic Valve Dysfunction Studying the SAPIEN 3 Interventional THV
Source: Edwards Lifesciences LLC
April 27, 2016 – April 26, 2025
Evaluation of the safety and efficacy of the Carag Bioresorbable Septal Occluder (CBSO) to treat patients with clinically significant secundum atrial septal defect
Source: atHeart Medical, LLC
February 28, 2021 – February 28, 2025
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation (SUMMIT) (the ¿Trial¿)
Source: Tendyne Holdings, Inc.
June 01, 2018 – February 28, 2025
Multicenter Early Feasibility Study of Congenital Pulmonic Valve Dysfunction Studying the SAPIEN 3 Transcatheter Heart Valve with the UAlterraU Adaptive Prestent
Source: Edwards Lifesciences LLC
July 20, 2018 – July 31, 2024
COMPASSION S3 PAS: COngenital Multicenter trial of Pulmonic vAlve dysfunction Studying the SAPIEN 3 interventIONal THV Post-Approval Study
Source: Edwards Lifesciences LLC
May 20, 2021 – May 19, 2024
Clinical Outcomes Assessment of the MitraCLip Percutaneous Therapy for High Surgical Risk Patients
Source: Evalve Inc.
July 01, 2012 – April 30, 2024
Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy using a Novel Device
Source: Edwards Lifesciences LLC
February 16, 2021 – February 15, 2024
Transcatheter Mitral Valve Replacement with the Medtronic Intrepid¿ TMVR System in patients with severe symptomatic mitral regurgitation ¿ APOLLO Trial
Source: Medtronic Inc.
January 13, 2021 – January 13, 2024
EARLY FEASIBILITY STUDY OF THE INTREPID¿ TMVR TRANSSEPTAL SYSTEM STUDY
Source: Medtronic Inc.
November 30, 2020 – November 29, 2023
Multicenter Study of Congenital Pulmonic Valve Dysfunction Studying the SAPIEN 3 Transcatheter Heart Valve with the Alterra Adaptive Prestent - Continued Access
Source: Edwards Lifesciences LLC
August 27, 2020 – August 26, 2023
CRD_947 Percutaneous MitraClipTM Device or Surgical Mitral Valve REpair in PAtients with PrImaRy MItral Regurgitation who are Candidates for Surgery (REPAIR-MR)
Source: Abbott Cardiovascular Systems, Inc
July 28, 2020 – July 27, 2023
Early Feasibility Study of the Edwards EVOQUE Tricuspid Valve Replacement System
Source: Edwards Lifesciences LLC
April 03, 2020 – April 02, 2023
Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional MR (COAPT) Continued Access Study
Source: Evalve Inc.
January 05, 2018 – January 04, 2023
Lim - MEDTRONIC CONSULTING
Source: Medtronic Inc.
June 13, 2018 – September 30, 2022
TMVR Pivotal Study Screen Committee Service
Source: Medtronic Inc.
September 20, 2017 – September 30, 2022
Evalve Training/Consulting Agreement
Source: Abbott Cardiovascular Systems, Inc
September 15, 2020 – September 14, 2022
Clinical Study of the Edwards EVOQUE Eos Mitral Valve Replacement System
Source: Edwards Lifesciences LLC
March 08, 2018 – March 07, 2022
Edwards PASCAL TrAnScatheter Valve RePair System in Tricuspid Regurgitation (CLASP TR) Early Feasibility Study
Source: Edwards Lifesciences LLC
February 10, 2019 – February 09, 2022
Trial to Evaluate Treatment with Abbott Transcatheter Clip Repair System in Patients with Moderate or Greater Tricuspid Regurgitation
Source: Evalve Inc.
February 06, 2019 – February 05, 2022
REPRISE IV: REpositionable Percutaneous Replacement of Stenotic Aortic Valve through Implantation of LOTUS Edge¿ Valve System in IntermediatE Surgical Risk Subjects
Source: Boston Scientific Corporation
June 26, 2020 – January 31, 2022
Early Feasibility Study of the Edwards FORMA Tricuspid Transcatheter Repair System
Source: Edwards Lifesciences LLC
January 16, 2019 – January 15, 2022
MD-INMD-CV-SL9PC-Edwards PASCAL CLASP IID Pivotal Clinical Trial
Source: Edwards Lifesciences LLC
December 18, 2018 – December 17, 2021
The CLASP Study - Edwards PASCAL TrAnScatheter Mitral Valve RePair System Study
Source: Edwards Lifesciences LLC
December 04, 2017 – December 03, 2021
MD-INMD-CV-RM5S-StJudeMedBus
Source: St. Jude Medical, Cardiology Division, Inc.
November 28, 2016 – November 27, 2021
Edwards Cardioband Tricuspid Valve Reconstruction System Early Feasibility Study No. 2017-19
Source: Edwards Lifesciences LLC
November 27, 2017 – November 26, 2021
MD-INMD The REFLECT Trial with respect to Sponsor's TriGuard(TM) HDH device
Source: Keystone Heart Ltd.
October 06, 2016 – April 05, 2021
CAP2 (Continued access to Prevail)
Source: Boston Scientific Corporation
February 05, 2013 – February 05, 2021
Using Drone-Based Hyperspectral Imagery to Map Individual Species of Invasive Plants in the Northern Blue Ridge Mountains of Virginia
Source: U.S. Department Of Agriculture
August 18, 2018 – December 31, 2020
Gore Septal Occluder Clinical Study
Source: W.L. Gore & Associates, Inc.
October 26, 2012 – July 31, 2020
Gore Septal Occluder Clinical Study
Source: W.L. Gore & Associates, Inc.
July 01, 2012 – July 31, 2020
MD-CVRC-CV Medtronic SURTAVI Study
Source: Bon Secours St. Mary's Hospital of Richmond, Inc.
July 06, 2015 – July 03, 2020
MitraClip EXPAND Steering Committee
Source: Evalve Inc.
May 07, 2018 – May 06, 2020
MD-CVRC Muscular VSD-Muscular VPA Study
Source: AGA Medical Corporation
July 01, 2012 – April 30, 2020
MD-PEDT Muscular VSD-Muscular VPA Study
Source: AGA Medical Corporation
June 02, 2009 – April 30, 2020
Assessment of the CARILLON Mitrol Contour System in Treating Functional Mitral Regurgitation Associated with Heart Failure
Source: Cardiac Dimensions, Inc.
November 08, 2018 – January 17, 2020
MD-CVRC Protocol Everest II - Endovascular Valve Edge to Edge Repair Study
Source: Evalve Inc.
July 01, 2012 – December 31, 2019
MD-CRVC Valve Education Center
Source: Evalve Inc.
July 01, 2012 – November 30, 2019
MD-INMD-CV Mitralign Percutaneous Tricuspid Valve Annulopasty System (PTVAS)
Source: Mitralign, Inc.
November 06, 2015 – November 01, 2019
Tricuspid Pivotal IDE Clinical Trial
Source: Evalve Inc.
October 26, 2018 – October 25, 2019
MD-INMD-CV-SL9PCMedtronicTAVR
Source: Bon Secours St. Mary's Hospital of Richmond, Inc.
June 10, 2016 – June 09, 2019
Mitralign Screen Committee Service Agreement
Source: Mitralign, Inc.
February 01, 2018 – February 01, 2019
Perceptual metrics in VR
Source: Google Inc.
May 15, 2017 – December 31, 2018
Health Care Professional Consultant Agreement
Source: Evalve Inc.
November 02, 2017 – November 01, 2018
MD-INMD-CV Closure of Atrial Septal Defects with the Amplatzer Septal Occluder (AS) Post Market Surveillance Study
Source: St. Jude Medical, Cardiology Division, Inc.
April 16, 2015 – October 31, 2018
MD-INMD-CV SALUS - The Direct Flow Medical Transcatheter Aortic Valve Replacement System a US Pivotal Trial
Source: Direct Flow Medical, Inc.
October 24, 2014 – February 27, 2018
MD-CVRC Claret Medical Sentinel IDE Study
Source: Claret Medical Inc.
December 10, 2014 – September 30, 2017
The Direct Flow Medical Transcathetar Aortio Valve Replacement System Pivolel Trial (SALUS) Study
Source: Bon Secours St. Mary's Hospital of Richmond, Inc.
July 06, 2015 – July 05, 2017
MD-INMD-ASD 15-04 Start-up Activity Invoice
Source: W.L. Gore & Associates, Inc.
November 21, 2016 – January 12, 2017
MD-CVRC Closure of Atrial Septal Defects with the AMPLATZER Septal Occluder - ASD PMS II
Source: St. Jude Medical, Cardiology Division, Inc.
July 01, 2012 – March 22, 2015
MD-CVRC Protocol ST1021 Watchman Left Atrial Appendage System for Embolic Protection in Patients
Source: Atritech, Inc.
July 01, 2012 – November 14, 2014
Closure of Atrial Septal Defects with the AMPLATZER Septal Occluder-ASD PMS II
Source: AGA Medical Corporation
March 22, 2010 – March 22, 2014
Valve Education Center
Source: Evalve Inc.
November 10, 2011 – November 30, 2013
Protocol ST1021 Watchman Left Atrial Appendage System for Embolic Protection in Patients
Source: Atritech, Inc.
August 16, 2005 – November 14, 2013
Protocol Everest II - Endovascular Valve Edge to Edge Repair Study
Source: Evalve Inc.
February 17, 2006 – September 16, 2013
Clinical Outcomes Assessment of gthe MitraClip Percutaneous Therapy for High Surgical Risk Patients
Source: Evalve Inc.
September 18, 2012 – January 31, 2013
  • 2011-2018 Best Doctors in America® List